In the latest in what will likely be a long line of deals, fast-growing RIA Aspiriant will merge in March with the Glowacki Group, which has $360 million in assets under management.

The merger is the second for $9 billion AUM Aspiriant in just three months. Most of its upcoming deals will serve as succession solutions for the smaller firms' principals and allow Aspiriant to continue to expand its national footprint, says Aspiriant CEO Rob Francais.

Register or login for access to this item and much more

All Financial Planning content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access